Related Experiment Video
Updated: Jan 27, 2026

Investigating Migraine-Like Behavior Using Light Aversion in Mice
Published on: August 11, 2021
Invited Commentary on Preventive Anti-Migraine Therapy (PAMT)
Sameer Jain1, Stephen D Silberstein2
1Pain Treatment Centers of America, Little Rock, AR, 72205, USA. paindocsj@gmail.com.
Abstract:
Migraine is a chronic paroxysmal neurological disorder characterized by multiphase attacks of head pain and a myriad of neurological symptoms. Chronic migraine causes a great personal and societal burden. Many patients are poorly responsive to, or non-compliant with, conventional migraine preventive therapies. For this reason, physicians are constantly looking for effective migraine prevention strategies. The recent introduction of an innovative pharmacological class useful for migraine prevention, namely monoclonal antibodies towards calcitonin gene-related peptide or its receptors, opens a new, immense therapeutic scenario. In this commentary, the development and efficacy of this novel class of preventive anti-migraine therapy have been discussed and compared with the conventional therapies of migraine prevention.
Related Concept Videos
Urinary Tract Calculi IV: Nutrition Therapy and Prevention
Cancer Prevention
Some...
Gene Therapy
Prevention of Further Absorption of Poison
Preventive Healthcare Services
Group Therapy

